erlotinib hydrochloride has been researched along with phosphatidylcholines in 2 studies
| Studies (erlotinib hydrochloride) | Trials (erlotinib hydrochloride) | Recent Studies (post-2010) (erlotinib hydrochloride) | Studies (phosphatidylcholines) | Trials (phosphatidylcholines) | Recent Studies (post-2010) (phosphatidylcholines) |
|---|---|---|---|---|---|
| 4,353 | 786 | 3,033 | 32,204 | 443 | 5,593 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Balabathula, P; Mandal, B; Mittal, NK; Thoma, LA; Wood, GC | 1 |
| He, Y; Su, Z; Xu, H; Xue, L; Zhang, C | 1 |
2 other study(ies) available for erlotinib hydrochloride and phosphatidylcholines
| Article | Year |
|---|---|
Development and in vitro evaluation of core-shell type lipid-polymer hybrid nanoparticles for the delivery of erlotinib in non-small cell lung cancer.
Topics: Antineoplastic Agents; Biological Transport; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Survival; Drug Delivery Systems; Drug Liberation; Erlotinib Hydrochloride; Humans; Lung Neoplasms; Microscopy, Electron, Transmission; Nanoparticles; Phosphatidylcholines; Phosphatidylethanolamines; Polyesters; Polyethylene Glycols; Protein Kinase Inhibitors; Tumor Stem Cell Assay | 2016 |
Co-delivery of erlotinib and doxorubicin by pH-sensitive charge conversion nanocarrier for synergistic therapy.
Topics: A549 Cells; Animals; Antineoplastic Agents; Apoptosis; Benzoates; Carcinoma, Lewis Lung; Cell Survival; Doxorubicin; Drug Carriers; Drug Liberation; Drug Synergism; Drug Therapy, Combination; Erlotinib Hydrochloride; Humans; Hydrogen-Ion Concentration; Male; Mice, Inbred C57BL; Nanoparticles; Phosphatidylcholines; Protein Kinase Inhibitors; Rats, Sprague-Dawley | 2016 |